,,iv  #aac? ,,congress  #a/ ,session    
,h4 ,,res4 #afa  ,,9 ,,! ,,h\se ,,(     
,,repres5tatives  ,april #ae1 #bjac ,mr4
 ,rog]s ( ,k5tucky 7= himself1 ,mr4     
,keat+1 ,mr4 ,wolf1 ,mr4 ,rahall1 ,mr4  
,grimm1 ,mr4 ,lyn*1 ,mr4 ,ti]ney1 & ,mr4
 ,ad]holt7 submitt$ ! foll[+ resolution2
 :i* 0 ref]r$ to ! ,committee on ,en]gy 
& ,comm]ce  ,,resolution  ,express+ !   
s5se ( ! ,h\se ( ,repres5tatives t !    
,food & ,drug ,adm9i/ration %\ld        
enc\rage ! use ( abuse-det]r5t          
=mulations ( drugs4  ,:]eas :5          
abuse-det]r5t =mulations ( a drug h be5 
develop$1 approv$1 & recogniz$ z        
effective by ! ,food & ,drug            
,adm9i/ration1 ! approval & m>ket+ (    
g5]ic v]sions t d n h abuse-det]r5t     
features are likely to prev5t a*ievem5t 
( ! public heal? purposes ( ! ef=ts to  
develop su* abuse-det]r5t =mulations2   
,:]eas ! ,(fice ( ,national ,drug       
,control ,policy & ! ,food & ,drug      
,adm9i/ration h = _m ye>s /rongly       
enc\rag$ manufactur]s ( opioid drug     

products to develop abuse-det]r5t       
=mulations design$ to prev5t or         
disc\rage ! abuse or misuse ( ^?        
products2 ,:]eas 9 response1 sev]al     
opioid drug manufactur]s h develop$     
abuse-det]r5t =mulations2 ,:]eas help+  
to r$uce ! level ( abuse ( opioid drug  
products is dep5d5t on ! widespread     
adoption ( new te*nologies & approa*es  
to ! saf] =mulation ( ^! drugs2 ,:]eas !
 ,commission] ( ,food & ,drugs has      
ackn[l$g$ t ! ,food & ,drug             
,adm9i/ration has ! au?ority "u curr5t  
law to require g5]ic v]sions ( products 
t h be5 =mulat$ or re=mulat$ )          
abuse-det]r5t features to h comp>able   
features2 & ,:]eas f\rte5 ,memb]s (     
,congress 9 a bip>tisan coalition h     
cosponsor$ ! ,/op ,tamp]+ )             
,prescription ,pills 7,,/opp7 ,act1 :i* 
w\ld simil>ly promote abuse-det]r5t     
te*nologies 9 addictive pa9kill]s3 ,n[1 
!re=e1 be x  ,t x is ! s5se ( ! ,h\se ( 
,repres5tatives t ! ,food & ,drug       
,adm9i/ration %\ld ex]cise its ackn[l$g$

 au?ority to--  7#a7 refuse to approve  
g5]ic v]sions ( non-abuse-det]r5t opioid
 products t h be5 replac$ 9 ! m>ket )   
abuse-det]r5t =mulations2 &  7#b7       
require g5]ic v]sions ( abuse-det]r5t   
opioid products to be =mulat$ )         
comp>able abuse-det]r5t features4